1. Home
  2. GLRE vs SRDX Comparison

GLRE vs SRDX Comparison

Compare GLRE & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLRE
  • SRDX
  • Stock Information
  • Founded
  • GLRE 2004
  • SRDX 1979
  • Country
  • GLRE Cayman Islands
  • SRDX United States
  • Employees
  • GLRE N/A
  • SRDX N/A
  • Industry
  • GLRE Property-Casualty Insurers
  • SRDX Medical/Dental Instruments
  • Sector
  • GLRE Finance
  • SRDX Health Care
  • Exchange
  • GLRE Nasdaq
  • SRDX Nasdaq
  • Market Cap
  • GLRE 480.7M
  • SRDX 415.4M
  • IPO Year
  • GLRE 2007
  • SRDX 1998
  • Fundamental
  • Price
  • GLRE $13.11
  • SRDX $30.29
  • Analyst Decision
  • GLRE
  • SRDX Buy
  • Analyst Count
  • GLRE 0
  • SRDX 2
  • Target Price
  • GLRE N/A
  • SRDX $43.00
  • AVG Volume (30 Days)
  • GLRE 170.4K
  • SRDX 91.6K
  • Earning Date
  • GLRE 08-05-2025
  • SRDX 07-30-2025
  • Dividend Yield
  • GLRE N/A
  • SRDX N/A
  • EPS Growth
  • GLRE N/A
  • SRDX N/A
  • EPS
  • GLRE 1.32
  • SRDX N/A
  • Revenue
  • GLRE $717,617,000.00
  • SRDX $121,575,000.00
  • Revenue This Year
  • GLRE N/A
  • SRDX N/A
  • Revenue Next Year
  • GLRE N/A
  • SRDX $3.19
  • P/E Ratio
  • GLRE $10.10
  • SRDX N/A
  • Revenue Growth
  • GLRE 2.79
  • SRDX N/A
  • 52 Week Low
  • GLRE $11.95
  • SRDX $26.00
  • 52 Week High
  • GLRE $15.82
  • SRDX $41.98
  • Technical
  • Relative Strength Index (RSI)
  • GLRE 34.27
  • SRDX 60.91
  • Support Level
  • GLRE $13.03
  • SRDX $30.50
  • Resistance Level
  • GLRE $14.15
  • SRDX $31.63
  • Average True Range (ATR)
  • GLRE 0.33
  • SRDX 0.92
  • MACD
  • GLRE -0.12
  • SRDX 0.10
  • Stochastic Oscillator
  • GLRE 5.23
  • SRDX 81.07

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

Share on Social Networks: